You are here Home Vaccines Vaccines Rotarix Details for Rotarix (rotavirus) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor GlaxoSmithKline Australia Administration route Oral Vaccine group Rotavirus vaccines Description: Registered for use in infants, with an upper age limit for dose 2 of 24 weeks. Live attenuated human rotavirus vaccine Each 1.5 mL monodose pre-filled oral applicator or squeezable tube contains: ≥106.0 cell culture infectious dose 50% (CCID50) of the RIX4414 human rotavirus strain, type G1P[8] di-sodium adipate Dulbecco’s modified Eagle medium sterile water For Product Information and Consumer Medicine Information about Rotarix visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Rotavirus Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
